Paul Tudor Jones Tudor Investment Corp
Paul Tudor Jones is the founder of Tudor Investment Corporation and a pioneering macro trader. He rose to prominence after navigating the 1987 market crash successfully and has since built a multi-strategy firm spanning global markets. Jones is widely associated with discretionary macro trading, risk management discipline, and high-profile philanthropic efforts in education and the environment.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Y
Alleghany Corp
Y
|
+$70.1M |
| 2 |
iShares MSCI Emerging Markets ETF
EEM
|
+$64.4M |
| 3 |
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
|
+$41.9M |
| 4 |
State Street Energy Select Sector SPDR ETF
XLE
|
+$40.7M |
| 5 |
Warner Bros
WBD
|
+$37.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CERN
Cerner Corp
CERN
|
+$103M |
| 2 |
PLAN
Anaplan, Inc.
PLAN
|
+$89.2M |
| 3 |
ANAT
American National Group, Inc. Common Stock
ANAT
|
+$44M |
| 4 |
ZNGA
ZYNGA INC. CL A COMMON
ZNGA
|
+$33.9M |
| 5 |
MGP
MGM Growth Properties LLC Class A common shares representing limited liability company interests
MGP
|
+$20M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.8% |
| 2 | Financials | 13.02% |
| 3 | Healthcare | 11.9% |
| 4 | Consumer Discretionary | 10.28% |
| 5 | Industrials | 8.92% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1751
Mativ Holdings
MATV
$676M
| $223K | 0.01% |
8,892
-12,533
| -58% | -$331K |
|
1752
PUT
Robert Half
RHI
$4.62B
| $223K | 0.01% |
+3,000
| New | +$285K |
|
1753
Sonoco
SON
$5.68B
| $223K | 0.01% |
+3,911
| New | +$233K |
|
1754
SPDR Gold Trust
GLD
$155B
| $222K | 0.01% |
1,319
-577
| -30% | -$101K |
|
1755
Hawkins
HWKN
$2.46B
| $222K | 0.01% |
+6,161
| New | +$233K |
|
1756
Victory Capital Holdings
VCTR
$7.14B
| $222K | 0.01% |
+9,217
| New | +$248K |
|
|
GTHX
1757
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
| $222K | 0.01% |
+44,964
| New | +$249K |
|
1758
PUT
GlobalFoundries
GFS
$25.2B
| $221K | 0.01% |
+5,500
| New | +$291K |
|
1759
CALL
CrowdStrike
CRWD
$194B
| $220K | 0.01% |
5,200
+1,600
| +44% | +$72.4K |
|
|
QVCGA
1760
DELISTED
QVC Group Inc Series A
QVCGA
| $220K | 0.01% |
1,533
-10,514
| -87% | -$2.04M |
|
1761
PUT
Louisiana-Pacific
LPX
$5.08B
| $219K | 0.01% |
+4,200
| New | +$269K |
|
1762
Weave Communications
WEAV
$583M
| $219K | 0.01% |
72,144
-11,209
| -13% | -$53.9K |
|
|
BIG
1763
CALL
DELISTED
Big Lots, Inc.
BIG
| $219K | 0.01% |
+10,400
| New | +$306K |
|
1764
CALL
Logitech
LOGI
$13.9B
| $218K | 0.01% |
4,200
-900
| -18% | -$55.4K |
|
1765
Bioventus
BVS
$958M
| $217K | 0.01% |
31,748
+8,648
| +37% | +$88.2K |
|
1766
CALL
Intrepid Potash
IPI
$510M
| $217K | 0.01% |
+4,800
| New | +$349K |
|
1767
Lear
LEA
$8.18B
| $217K | 0.01% |
1,727
-8,745
| -84% | -$1.15M |
|
1768
MGIC Investment
MTG
$6.38B
| $217K | 0.01% |
17,209
-110,087
| -86% | -$1.45M |
|
1769
PUT
Shopify
SHOP
$193B
| $217K | 0.01% |
+7,000
| New | +$299K |
|
1770
Stoke Therapeutics
STOK
$2.09B
| $217K | 0.01% |
16,424
-1,095
| -6% | -$16.6K |
|
1771
CALL
T-Mobile US
TMUS
$196B
| $216K | 0.01% |
1,600
-2,500
| -61% | -$326K |
|
1772
CALL
Ameriprise Financial
AMP
$49.6B
| $215K | 0.01% |
+900
| New | +$241K |
|
1773
PUT
RingCentral
RNG
$5.6B
| $215K | 0.01% |
+4,100
| New | +$311K |
|
1774
Park-Ohio Holdings
PKOH
$649M
| $214K | 0.01% |
+13,473
| New | +$189K |
|
1775
CALL
Waste Management
WM
$90.5B
| $214K | 0.01% |
1,400
-6,300
| -82% | -$987K |
|
Similar funds
Paul Tudor Jones's Q2 2022 Portfolio in Review
As of Q2 2022, Paul Tudor Jones held 2,681 positions worth $3.81B, down 11% from $4.27B the previous quarter. Its ten largest holdings account for 10% of the portfolio.
Paul Tudor Jones deployed $332M of net new capital in Q2 2022, opening 766 new positions and adding to 644 existing holdings. Its largest new stake was Biohaven Pharmaceutical Holding Company Ltd.: 327,735 shares worth $47.8M.
By sector, the portfolio is most concentrated in Technology at 16% of assets, down from 20% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Liberty Broadband Class C, an estimated $18.4M trimmed.
- Paul Tudor Jones's largest Q2 2022 buy was Biohaven Pharmaceutical Holding Company Ltd.: 327,735 shares worth $47.8M.
- Paul Tudor Jones added most to Alleghany Corp in Q2 2022, an estimated $70.1M increase.
- Paul Tudor Jones's biggest Q2 2022 reduction was Liberty Broadband Class C, cutting an estimated $18.4M.
- Paul Tudor Jones fully exited Cerner Corp in Q2 2022, selling an estimated $103M.
- Paul Tudor Jones's ten largest holdings make up 10% of its $3.81B portfolio in Q2 2022.
- Paul Tudor Jones opened 766 new positions and closed 638 in Q2 2022.
- Paul Tudor Jones's portfolio value fell 11% quarter-over-quarter to $3.81B.
Based on Tudor Investment Corp's 13F filing for Q2 2022, filed 15 Aug 2022.